A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma

NCT05336266 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer
Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer

Interventions

DRUG: Ketorolac Tromethamine

Sponsor

Andrew Hendifar, MD

Collaborators

[object Object]